BioScience Health Innovations reported revenue of $1.04M and net income of -$0.19M for the quarter ended Jun 2026, down 41.0% year over year. This income statement covers 27 quarters of results from Nov 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Nov2019 | Feb2020 | May2020 | Aug2020 | Nov2020 | Feb2021 | May2021 | Aug2021 | Nov2021 | Feb2022 | May2022 | Aug2022 | Nov2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||
| Revenue | 0.03M | 0.07M | 0.19M | 0.30M | 0.28M | 0.38M | 0.57M | 0.61M | 1.23M | 1.76M | 1.13M | 1.57M | 0.75M | 1.04M | |||||||||||||
| Cost of RevenueCost of Rev | 0.00M | 0.01M | 0.03M | 0.07M | 0.04M | 0.07M | 0.15M | 0.27M | 0.33M | 0.68M | 0.43M | 1.00M | 0.27M | 0.38M | |||||||||||||
| Gross Profit | 0.03M | 0.06M | 0.16M | 0.24M | 0.23M | 0.31M | 0.42M | 0.34M | 0.90M | 1.07M | 0.70M | 0.57M | 0.49M | 0.66M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 0.00M | 0.01M | 0.03M | 0.05M | 0.03M | 0.09M | 0.14M | 0.21M | 0.26M | 0.28M | 0.22M | 0.35M | 0.30M | 0.43M | 0.54M | 0.58M | 0.66M | 0.63M | 0.80M | ||||||||
| Other Operating ExpensesOther Opex | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.03M | 0.04M | 0.08M | 0.13M | 0.07M | 0.09M | 0.07M | |||||||||||||
| Operating ExpensesOpex | 0.00M | 0.01M | 0.03M | 0.05M | 0.03M | 0.10M | 0.15M | 0.22M | 0.27M | 0.29M | 0.24M | 0.37M | 0.33M | 0.47M | 0.62M | 0.71M | 0.73M | 0.72M | 0.88M | ||||||||
| Operating IncomeOp. Inc | -0.00M | -0.01M | -0.03M | -0.05M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | 0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.22M | ||||||||
| EBIT | -0.00M | -0.01M | -0.03M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | 0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.22M | |||||||
| Non-operating items | |||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.01M | ||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||
| EBT | -0.00M | -0.01M | -0.02M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | 0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.22M | |||||||
| Tax ProvisionsTaxes | 0.02M | -0.03M | |||||||||||||||||||||||||
| Profit After TaxPAT | -0.00M | -0.01M | -0.02M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | 0.01M | 0.43M | 0.46M | -0.01M | -0.23M | -0.23M | -0.19M | |||||||
| Income from Continuing OperationsIncome (Continuing) | -0.00M | -0.01M | -0.02M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | -0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.19M | |||||||
| Consolidated Net IncomeConsol Net Inc. | -0.00M | -0.01M | -0.02M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | -0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.19M | |||||||
| Income towards Parent CompanyParent Net Inc | -0.00M | -0.01M | -0.02M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | -0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.19M | |||||||
| Net Income towards Common StockholdersNet Income | -0.00M | -0.01M | -0.02M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | -0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.19M | |||||||
| Additional items | |||||||||||||||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 | -0.02 | -0.02 | |||||||
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 | -0.02 | -0.02 | |||||||||||||||
| Shares Outstanding | 5.46M | 5.46M | 5.46M | 5.46M | 5.46M | 5.46M | 13.86M | 39.84M | 40.36M | 33.76M | 41.39M | 41.60M | 42.09M | 41.93M | 43.92M | 43.92M | 10.98M | 10.98M | 11.38M | 11.68M | |||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 40.36M | 33.76M | 41.39M | 42.02M | 42.09M | 42.35M | 44.34M | 44.34M | 10.98M | 11.40M | 11.38M | 11.68M | |||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 5.46M | 5.46M | 5.46M | 5.46M | 5.46M | 5.46M | 13.86M | 40.31M | 40.79M | 33.76M | 41.60M | 41.60M | 42.10M | 43.92M | 43.92M | 43.92M | 10.98M | 10.98M | 10.98M | 11.75M | |||||||
| EBITDA | -0.00M | -0.01M | -0.03M | -0.05M | -0.00M | -0.03M | -0.07M | -0.09M | -0.06M | -0.04M | -0.05M | 0.07M | 0.06M | 0.01M | 0.43M | 0.46M | -0.01M | -0.16M | -0.23M | -0.22M | |||||||
| Tax Rate | 242.82% | 14.75% |